Insider Trading July 22, 2026 10:15 PM

Columbia Financial Director Noel Holland Acquires $150,000 in CLBK Shares

Executive expands stake amid ongoing corporate restructuring and merger completion

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
CLBK

Noel R. Holland, a director at Columbia Financial, Inc., has acquired 15,000 shares of the company's common stock, valued at $150,000. The transaction occurred on July 20, 2026, with the shares purchased at $10.00 each. This acquisition adds to Holland's existing indirect holdings through various deferred compensation and equity plans. The purchase comes as Columbia Financial continues to navigate significant corporate changes, including the completion of its merger with Northfield Bancorp, Inc. and the transition from a mutual holding company structure to a public stock form.

Columbia Financial Director Noel Holland Acquires $150,000 in CLBK Shares
CLBK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Noel R. Holland acquired 15,000 shares at $10.00 per share, bringing his total indirect holdings to over 138,000 shares across various deferral and equity plans.
  • Columbia Financial has finalized its merger with Northfield Bancorp, completing its transition from a mutual holding company to a publicly traded entity with full public ownership.
  • The stock has appreciated 63% over the past year to $10.94, though valuation metrics suggest potential overvaluation with a P/E ratio of 20.05.

Noel R. Holland, a director at Columbia Financial, Inc., has executed a significant acquisition of the company's common stock. On July 20, 2026, Holland purchased 15,000 shares, representing a total transaction value of $150,000. Each share was acquired at a price of $10.00. This purchase increases his indirect ownership stake in the financial institution through established compensation and deferral vehicles.

Following this recent acquisition, Holland's indirect holdings are distributed across multiple plans. He currently holds 29,674 shares through a Stock-Based Deferral Plan. Additionally, he possesses 109,316 shares indirectly held via a SEP-IRA. The director also maintains 6,494 shares indirectly through stock awards granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan. These specific shares are scheduled to vest on March 12, 2027. Furthermore, Holland holds exercisable options to purchase 183,246 shares of common stock. These options carry an exercise price of $7.10 and were originally granted on July 23, 2020. They are fully vested and remain exercisable until their expiration date on July 23, 2029.

The insider transaction occurs against a backdrop of substantial structural and operational changes at Columbia Financial. The company has recently completed its conversion from a mutual holding company structure. This process included the finalization of its merger with Northfield Bancorp, Inc. The completion of these steps means that Columbia Bank is now fully owned by Columbia Financial. Consequently, Columbia Financial is entirely owned by public stockholders. The Federal Reserve Board approved the necessary applications to facilitate this transition to a stock form and the acquisition of Northfield Bancorp.

Supporting this structural shift, Columbia Financial has engaged Keefe, Bruyette & Woods, Inc. to manage the sale of its common stock. The engagement covers both subscription offerings and community offerings. Keefe, Bruyette & Woods will serve as the lead-left book running manager for any firm commitment underwritten offering related to this process.

Leadership adjustments accompany these corporate developments. Thomas Splaine, Jr. has been appointed as the principal financial officer and principal accounting officer for SEC reporting matters at Columbia Financial. Splaine has been serving in the capacity of Executive Vice President and Chief Financial Officer since January. These personnel changes reflect the company's ongoing strategic adjustments and leadership developments during this transition period.

Market data indicates that CLBK stock is currently trading at $10.94. This represents an increase of 63% over the past year. Valuation metrics suggest the stock may be trading at elevated levels. Analysis indicates a P/E ratio of 20.05, which points to potential overvaluation at current price points. Investors monitoring the stock should consider these valuation indicators alongside insider activity and corporate restructuring efforts.

Risks

  • The stock's elevated P/E ratio of 20.05 suggests potential overvaluation, which could impact future price stability and investor returns in the financial sector.
  • The completion of the merger and transition to a public stock form introduces execution risks related to integrating operations and managing the newly public capital structure.
  • Leadership transitions, including the appointment of new principal financial and accounting officers, may introduce short-term operational adjustments during the strategic restructuring.

More from Insider Trading

Greenland Mines Director Accumulates Shares Amid Strategic Expansion Jul 23, 2026 Bank7 Executive Jason Estes Executes Stock Sales Totaling $247,668 Amid Q2 Earnings Miss Jul 23, 2026 Invesco Quality Municipal Income Trust Portfolio Manager Expands Stake with Recent Purchase Jul 23, 2026 Total Return Securities Fund Director Acquires Shares Amid Trading Near 52-Week Low Jul 23, 2026 VeriSign Executive Chairman D. James Bidzos Offloads $892,465 in Common Stock Jul 23, 2026